- Report
- May 2024
- 200 Pages
Global
From €3777EUR$4,150USD£3,238GBP
- Report
- February 2025
- 222 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- November 2024
- 166 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- November 2024
- 156 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- October 2024
- 213 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- October 2024
- 157 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- August 2024
- 145 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- July 2024
- 172 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- July 2024
- 134 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- July 2024
- 139 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- July 2024
- 130 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- July 2024
- 153 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- May 2024
- 175 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- March 2025
- 186 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- February 2025
- 190 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- April 2025
- 185 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- February 2025
- 180 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- February 2025
- 182 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- February 2025
- 183 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- January 2025
- 185 Pages
Global
From €4095EUR$4,500USD£3,511GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more